Cambridge Investment Research Advisors
RTO icon

Cambridge Investment Research Advisors’s Rentokil RTO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Sell
7,206
-757
-10% -$23.9K ﹤0.01% 3565
2025
Q4 		$235K Sell
7,963
-2,581
-24% -$71.7K ﹤0.01% 3436
2025
Q3 		$266K Sell
10,544
-2,371
-18% -$57.8K ﹤0.01% 3219
2025
Q2 		$310K Sell
12,915
-15
-0.1% -$348 ﹤0.01% 2949
2025
Q1 		$296K Buy
12,930
+3,993
+45% +$96.4K ﹤0.01% 2880
2024
Q4 		$226K Buy
+8,937
New +$226K ﹤0.01% 3090
2024
Q3 		– Sell
-15,103
Closed -$448K – 3516
2024
Q2 		$448K Buy
15,103
+886
+6% +$24.6K ﹤0.01% 2386
2024
Q1 		$429K Buy
+14,217
New +$394K ﹤0.01% 2401

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Cambridge Investment Research Advisors's RTO Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Rentokil (RTO) stake by 9.5% in Q1 2026, selling an estimated $23.9K and leaving 7,206 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #3565.

Cambridge Investment Research Advisors first reported a position in RTO in Q1 2024 and has held it in 8 quarters since. The position peaked at $448K in Q2 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Cambridge Investment Research Advisors held 7,206 shares of Rentokil worth $227K as of Q1 2026.
  • Cambridge Investment Research Advisors sold 757 Rentokil shares in Q1 2026, an estimated $23.9K.
  • Rentokil made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3565 holding.
  • Cambridge Investment Research Advisors first reported a position in Rentokil in Q1 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's Rentokil position peaked at $448K in Q2 2024.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.